Marcia Angell is a prominent figure in American medicine and publishing, renowned for her critical perspectives on the pharmaceutical industry and healthcare systems. As a former editor of the New England Journal of Medicine, she has been influential in shaping medical publishing and has a strong background in medical research and policy debate. Her work often emphasizes the ethical dilemmas and conflicts of interest that pervade the medical field, particularly regarding the influence of pharmaceutical companies on medical practice and research outcomes. Throughout her career, Angell has written extensively about the challenges facing healthcare in the United States, advocating for reforms that prioritize patient well-being over corporate profit. She argues for greater transparency in medical research and the need for regulations that hold pharmaceutical companies accountable for their practices. Her critique of market-driven healthcare highlights the negative effects on patients and the quality of care, suggesting that a shift towards a more socially responsible model is essential. Angell’s contributions have sparked crucial conversations about the integrity of medical science and the importance of independent research. Her insights continue to resonate in discussions around healthcare policy, making her a key voice in the ongoing conversation about how to improve the medical landscape for both practitioners and patients. Marcia Angell is a distinguished author and former editor of the New England Journal of Medicine. Her critical views have significantly influenced discussions surrounding the pharmaceutical industry and healthcare reform. Angell advocates for transparency and accountability in medical research, aiming to enhance patient care and ethical standards in medicine.